Ethyl dirazepate is a benzodiazepine derivative used primarily in pharmacological research to study its effects on the central nervous system. It acts by enhancing the activity of the neurotransmitter GABA, which modulates neuronal excitability and is associated with anxiolytic, sedative, and muscle relaxant effects. Research explores its potential for treating anxiety disorders, insomnia, and related psychiatric conditions. However, it remains in the experimental stage and is not approved for clinical or medical use.